top of page

Medical-Grade Air Protection

Trusted by hospitals, surgeries and ambulances worldwide.

Reduction of live SARS-CoV-2 by 99.997%

Independently tested by Innovative Bioanalysis, Inc.

AUTHORS: Dr. Dana Yee M.D, Clinical Pathologist and Medical Director; Sam Kabbani, MS, BS, MT(ASCP), CLS, Chief Scientific Officer; Albert Brockman, Chief Biosafety Officer; Kevin Noble, Chief Operating Officer.

Header
Novaerus logo_round.png

Professional Air Dis-Infection for Your Home & Business

Novaerus NV200_slide_1.png

 HOME & OFFICE 

 The compact NV200 is ideal for small rooms in the home and office. 

Products slideshow
Novaerus NV200_box.png

NV 200
NV 200 Portable Air Dis-infection Device

 

The NV 200 is suitable for smaller shared office spaces or individual rooms in a house. It can be placed on a countertop, stand-alone or mounted on a wall. It processes 80 m3/hr (cubic metres of air an hour).

Novaerus NV800_box.png

NV 800
NV 800 Portable Air Dis-infection Device

This wall-mounted unit is ideal for large rooms or larger shared spaces including offices or classrooms. It processes 260 m3/hr (cubic metres of air an hour).

Novaerus Defend 1050_box.png

Defend 1050
Defend 1050 Portable Air Dis-infection Device

Designed for rapid remediation in large spaces and situations with a high risk of infection. It is a free-standing unit which can be easily wheeled to any plug outlet. It processes 906 m3/hr (cubic metres of air an hour).

Products

Customer Testimonials

Blog_ISP.png

 International School of Prague, Czech Rep. 

"

“Safety is our top priority at the International School of Prague. Providing a safe educational environment for our staff and students is a commitment we view as both an individual and collective responsibility. We knew COVID was airborne and came to the conclusion early on that we must address this fact head-on. We researched the best-in-class solutions that could be used directly in the classroom with staff and students present. NOVAERUS was the obvious solution with their 'always on' plasma technology operating continuously in the background to eliminate infectious pathogens and allergens from the air. We are confident in our choice, as this professional medical technology is trusted by hospitals and ambulances worldwide to disinfect the air.”

– Barry Freckmann, Finance & Operations Director, International School of Prague

"

Testimonials

The first line of protection against viruses and bacteria
 

NanoStrike is the core, patented technology that powers all Novaerus portable air dis-infection devices.

This plasma-based nanotechnology kills all airborne microorganisms on contact providing the first line of protection against viruses and bacteria.

Slide_1.gif
Gif
Video - plasma
3 claims
Kills & Protects.png

Kills & Protects

Kills Airborne viruses with patented plasma technology to safely restore & maintain healthy air quality.

Bacteria & Mould.png

Bacteria & Mould

Novaerus devices destroy airborne bacteria & mould spores effectively and is perfect for almost all home and business environments.

Dust & Pollen.png

Dust & Pollen

Novaerus plasma based air dis-infection devices work to reduce dust, pollen and pet dander.

Indipendantly Tested

Test Results.png
  1. Tested on MS2 Bacteriophage, a surrogate for SARS-CoV-2 (2020 - Efficacy of the Novaerus NV1050 device against Aerosolized MS2 Virus, Aerosol Research and Engineering Laboratories)

  2. Tested on Human parainfluenza type 3 (HPIV3), a commonly used surrogate for Measles. (2019 – To assess the impact of an air purifier on Human parainfluenza virus Type 3,  Airmid Healthgroup)

  3. Tested on MS2 Bacteriophage, a surrogate for SARS-CoV-2 (2020 - Efficacy of the Novaerus NV1050 device against Aerosolized MS2 Virus, Aerosol Research and Engineering Laboratories)

  4. Tested on MS2 Bacteriophage, a surrogate for Norovirus (Tested on MS2 Bacteriophage, a commonly used surrogate for Norovirus (2005 - Survival of viruses on fresh produce, using MS2 as a surrogate for Norovirus, Dawson DJ et al.)

  5. Tested on MS2 Bacteriophage, a surrogate for Influenza (2010 – Evaluation of filters for the sampling and quantification of RNA Phage Aerosols, Louis Gendron et al.)

  6. Tested on Mycobacterium smegmatis, a commonly used surrogate for Mycobacterium tuberculosis (2007 - Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis, Chaturvedi V et al.)

  7. Tested on Staphylococcus epidermidis, a commonly used surrogate for MRSA. (2011 – Aerosol survival of Staphylococcus epidermidis, Thompson KA et al.)

Indipendantly Tested

Cleaner Air Means Cleaner Hands and Surfaces

Hand hygiene and surface disinfection have long been the international gold standard for infection control in healthcare environments. But as our hospitals become more crowded, infections become harder to treat, and costs become unmanageable, traditional protocols need reinforcement. Novaerus air dis-infection technology closes the loop in infection control.
 

Sneeze.png
Clean hands, surfaces & air

NOVAERUS uses patented active purification technology to continuously pull contaminated indoor air across internal short-exposure plasma coils, deactivating airborne microorganisms and viruses at the DNA level.

Download Brochure

Protect your business. Protect your customers with Novaerus.

Send us your contact details and we'll be happy to call, or email you back to discuss your needs and what Novaerus product is right for your home, office or business premise.

Thanks for submitting!

Request a Quote

Evidence Supported by Data

Graph_1.jpg
Data Slideshow

Demo Videos, Explainers and More...

Novaerus Videos

Novaerus Videos
Search video...
Defend 1050 Animation

Defend 1050 Animation

00:49
Play Video
Improve Indoor Air Quality in Schools with Novaerus

Improve Indoor Air Quality in Schools with Novaerus

01:36
Play Video
Novaerus Protect 800

Novaerus Protect 800

01:04
Play Video
The Scare in the Air - MRSA

The Scare in the Air - MRSA

01:01
Play Video
Videos
Studies & Clinical Trials

Lab Studies & Clinical Trials

bottom of page